DEVELOPMENT AND VALIDATION OF A PROGNOSTIC SCORE FOR PREDICTING OUTCOMES IN PATIENTS UNDERGOING LIVING DONOR LIVER TRANSPLANTATION
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 514
- 试验地点
- 1
- 主要终点
- TO DEVELOP AND VALIDATE THE ROLE OF NEW SCORE IN LIVER TRANSPLANT RECIPIENTS IN PREDICTING EARLY MORTALITY
研究概览
简要总结
Liver transplantation is a viable treatment option for patients with end stage liver disease, hepatocellular carcinoma, fulminant hepatitis. The outcome of liver transplant has been improved in later days due to advancements in surgical techniques , immunosuppression , enhanced knowledge in managing the allograft recipient.
Despite the multiple options , there is no agreement on the best scoring system to predict outcomes after liver transplant.The presently used scores have poor sensitivity and specificity in predicting the outcomes after the surgery.
The anaesthesia and surgical factors play a very important role in predicting the outcome of surgery. The outcome after surgery also predominantly depends upon the disease severity, patient factors. None of the previous scores have included patient factors like sarcopenia, MELD-Na and anaesthesia & surgical factors (fluid requirement including blood transfusion, inotropic support, cold ischemia time ,warm ischemia time, GRWR ) into a simple single score. So we aimed to consolidate all these factors into a new scoring system .
Hence, the aim of the present study is to develop a novel scoring system to predict the outcome after the LDLT.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)(—)
- 性别
- All
入选标准
- •PATIENTS WHO HAD LIVING DONOR LIVER TRANSPLANTATION
- •PATIENTS DIAGNOSED WITH CHRONIC LIVER DISEASE.
排除标准
- •ACUTE LIVER FAILURE
- •ACUTE ON CHRONIC LIVER FAILURE
- •HEPATOCELLULAR CARCINOMA
- •PAEDIATRIC POPULATION.
结局指标
主要结局
TO DEVELOP AND VALIDATE THE ROLE OF NEW SCORE IN LIVER TRANSPLANT RECIPIENTS IN PREDICTING EARLY MORTALITY
时间窗: 28 days and 6 months
次要结局
- To study the risk factors associated with one year mortality in patients undergoing living donor liver transplantation(1 year)
研究者
Dr Gaurav Sindwani
INSTITUTE OF LIVER AND BILIARY SCIENCES
